0.46USD
21.59 MUSD
235.64 MUSD
34.68 M
About Puma Biotechnology Inc
Sector
CEO
Alan H. Auerbach
Headquarters
Los Angeles
Website
Employees (FY)
185
Founded
2010
ISIN
US74587V1070
FIGI
BBG0018YXYX7
Puma Biotechnology, Inc. is a biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. It focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. The company was founded by Alan H. Auerbach on September 15, 2010 and is headquartered in Los Angeles, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of PBYI is 5.35 USD — it has increased by 1.52% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Puma Biotechnology Inc stocks are traded under the ticker PBYI.
Puma Biotechnology Inc is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Puma Biotechnology Inc has a max estimate of 7.00 USD and a min estimate of 2.00 USD.
PBYI earnings for the last quarter are 0.12 USD whereas the estimation was 0.08 USD which accounts for 56.52% surprise. Estimated earnings for the next quarter are 0.30 USD. See more details about Puma Biotechnology Inc earnings.
Puma Biotechnology Inc revenue for the last quarter amounts to 56.10 M USD despite the estimated figure of 57.95 M USD. In the next quarter revenue is expected to reach 73.55 M USD.
Yes, you can track Puma Biotechnology Inc financials in yearly and quarterly reports right on TradingView.
Like other stocks, PBYI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Puma Biotechnology Inc stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 185.00 employees. See our rating of the largest employees — is Puma Biotechnology Inc on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Puma Biotechnology Inc EBITDA is 44.78 M USD, and current EBITDA margin is 19.01%. See more stats in Puma Biotechnology Inc financial statements.